Health

Results: 6565-6576 of 8695

PR Newswire associated0

Ellipses' next generation selective RET inhibitor EP0031/A400 cleared to start Phase 2

Epsilogen Appoints Ashley Nagle as Chief Business Officer and Peter Finan as Non-Executive Chairman as Part of Broader Company Expansion

PR Newswire associated0

Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace

Renovion Announces Positive Top-Line Results from Phase 2 CLIMB Study of ARINA-1 (RVN-301) in Patients with Non-Cystic Fibrosis Bronchiectasis

LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer

Photocure ASA - Notice of the Annual General Meeting 23 May 2024

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference

Statement from The Sunbed Association in response to Melanoma Focus Report on Sunbeds

TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition

Real Chemistry Introduces Iris: An Insights-as-a-Service Platform Delivering Timely Insights on the Obesity Market and the Growing Influence of GLP-1 Therapies

PR Newswire associated0

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia